Lower percentages of Black, Hispanic and Asian adults with asthma used inhaled corticosteroid, long-acting beta-agonist and long-acting muscarinic antagonist inhalers vs. white adults in 2014 to 2023, according to results published in JAMA.This disparity is likely due to socioeconomic characteristics and health care access factors, according to researchers.